Akèy › Kansè (tout kalite) › Michigan › Grand Rapids
Etid klinik pou Kansè (tout kalite) nan Grand Rapids, MI
28 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Grand Rapids (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
Ap rekriteFaz 2
- START Midwest ( Site 1103), Grand Rapids
REC-7735 in Participants With Solid Tumors
Ap rekriteFaz 1/2
- START Midwest, Grand Rapids
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Ap rekriteFaz 1
- START Midwest /ID# 279035, Grand Rapids
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Ap rekriteFaz 1/2
- Corewell Health ( Site 4001), Grand Rapids
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Ap rekriteFaz 1
- Start Midwest, Grand Rapids
A Study of JNJ-87890387 for Advanced Solid Tumors
Ap rekriteFaz 1
- Start Midwest, Grand Rapids
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Ap rekriteFaz 3
- Cancer And Hematology Centers Of Western Michigan - Grand Rapids /ID# 279955, Grand Rapids
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Ap rekriteFaz 2
- Cancer Research Consortium of West Michigan, Grand Rapids
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Ap rekriteFaz 1/2
- START Midwest, Grand Rapids
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Ap rekriteFaz 1/2
- Corewell Health ( Site 3001), Grand Rapids
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Ap rekriteFaz 1
- START - Midwest Cancer Research Center, Grand Rapids
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ap rekriteFaz 3
- The Cancer & Hematology Centers, Grand Rapids
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Ap rekriteFaz 3
- Cancer and Hematology Centers of Western Michigan, Grand Rapids
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Ap rekriteFaz 1
- START Midwest, Grand Rapids
Project: Every Child for Younger Patients With Cancer
Ap rekriteEtid obsèvasyon
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
Ap rekriteFaz 1/2
- Site 04, Grand Rapids
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
Ap rekriteFaz 1
- START Midwest, Grand Rapids
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
Ap rekriteFaz 1
- START Midwest, Grand Rapids
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Ap rekriteFaz 3
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer
Ap rekriteFaz 1Volontè an sante akeyi
- BAMF Health Inc., Grand Rapids
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- START Midwest, Grand Rapids
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Ap rekriteFaz 1/2
- START Midwest, Grand Rapids
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
Ap rekriteFaz 1
- GSK Investigational Site, Grand Rapids
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Ap rekriteFaz 1
- Context Investigational Site, Grand Rapids
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Ap rekriteFaz 1
- START Midwest, Grand Rapids
A Study of YL242 in Subjects With Advanced Solid Tumors
Ap rekriteFaz 1/2
- US-206, Grand Rapids
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
Ap rekriteEtid obsèvasyon
- Corewell Health, Grand Rapids
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Ap rekrite
- Mercy Health Saint Mary's, Grand Rapids
- Spectrum Health at Butterworth Campus, Grand Rapids
Etid Kansè (tout kalite) nan lòt vil
- Houston, TX121 etid
- New York City, NY109 etid
- Boston, MA85 etid
- Los Angeles, CA74 etid
- Nashville, TN65 etid
- Philadelphia, PA59 etid
- Washington, DC58 etid
- Durham, NC58 etid
- Chicago, IL51 etid
- Atlanta, GA49 etid
- Seattle, WA49 etid
- Arlington, VA48 etid
Lòt etid nan Grand Rapids
- Kansè Poumon ki pa ti selil44 etid
- Kansè kolorektal40 etid
- Kansè nan tete26 etid
- Kansè ovè24 etid
- Kansè Metastatik22 etid
- Kansè pwostat19 etid
- Kansè Endomèt18 etid
- Kansè lestomak18 etid
- Kansè pankreyas18 etid
- Melanom17 etid
- Karsinòm selil skuamèz tèt ak kou15 etid
- Kansè tete negatif triple15 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.